Skip to main content
Clinical Trials/ITMCTR2200006505
ITMCTR2200006505
Not Yet Recruiting
Phase 1

A prospective, randomized and controlled clinical study on the treatment of diabetes nephropathy with chronic kidney disease (stage 3-4) by Chen's Tangshen recipe

onghua Hospital Shanghai University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
onghua Hospital Shanghai University of Traditional Chinese Medicine
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
onghua Hospital Shanghai University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) DKD patients with clinical diagnosis of CKD stage 3\~4
  • (2\) Aged 18 to 80 years old;
  • (3\)Patients with type 2 diabetes who have been taking antidiabetic drugs or insulin treatment for half a year or more, with HbA1c\=8%;
  • (4\) Patients with 24\-hour urine protein quantification\=0\.3g
  • (5\)The patients were informed and signed the informed consent.

Exclusion Criteria

  • 1\. Patients with type 1 diabetes;
  • 2\. Abnormal liver function test results (AST or ALT or alkaline phosphatase \> 3 times ULN), or other known patients with acute and chronic active hepatitis and cirrhosis;
  • 3\. Previous history of EGFR decline \> 30% within 2\-3 months after using ACEI / ARB drugs;
  • 4\. Those who use hormone or immunosuppressant due to kidney disease or kidney transplantation;
  • 5\. Other chronic kidney diseases (such as chronic glomerulonephritis, chronic pyelonephritis, ischemic kidney disease, etc.) during screening;
  • 6\. Patients with blood pressure lower than 110 / 60mmHg (without antihypertensive drugs) before screening;
  • 7\. Those whose blood pressure was continuously higher than 180 / 100mmHg two weeks before screening;
  • 8\. Those with blood potassium level \> 5\.5 mmol / L during screening;
  • 9\. Patients with severe acute diabetes complications (ketoacidosis, lactic acidosis, hypertonic nonketotic diabetes coma, hypoglycemic coma) within 6 months before screening;
  • 10\. Patients with acute coronary syndrome, heart failure (NYHA score III\-IV), or surgical treatment for heart related diseases, stroke or poor prognosis of stroke within the first 3 months of screening;

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
A prospective, randomized and controlled clinical study of traditional Chinese medicine (Astragalus / Panax notoginseng) combined with a new oncolytic virus / fusion cell vaccine in the treatment of advanced liver cancer and lung cancerung cancer, liver cancer\Various malignant tumors
ITMCTR2000003215The First Affiliated Hospital of Guangxi University of traditional Chinese Medicine
Recruiting
Phase 1
A prospective, observer-blind, randomized clinical trial to investigate and compare the clinical efficacy of Chloroprocaine 3% gel and Oxybuprocaine 0.4% eye drops anesthesia for clinical practice in pediatric population.male/female outpatients, aged 0-17 years scheduled to undergo ocular exams with a need of ocular surface anesthesia.Therapeutic area: Diseases [C] - Eye Diseases [C11]
CTIS2023-504477-21-01Sintetica S.A.74
Active, Not Recruiting
Phase 1
A prospective, observer-blind, randomized clinical trial to investigate and compare the clinical efficacy of Chloroprocaine 3% gel and Oxybuprocaine 0.4% eye drops anesthesia for clinical practice in pediatric population.male/female outpatients, aged 0-17 years scheduled to undergo ocular exams with a need of ocular surface anesthesia.Therapeutic area: Diseases [C] - Eye Diseases [C11]
CTIS2023-504477-21-00Sintetica S.A.74
Completed
N/A
The therapeutic effect of platelet enriched blood plasma for treating knee osteoarthritisHealth Condition 1: null- OSTEOARTHRITIS OF THE KNEE
CTRI/2018/03/012293Department Of Orthopaedics SVRR Government General Hospital Tirupati100
Active, Not Recruiting
N/A
A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin® Once liquid gel compared with Lyclear 1% permethrin crème rinse in the treatment of head lice - Hedrin Once versus Lyclear against head liceHead louse infestation (pediculosis capitis)MedDRA version: 13.1Level: LLTClassification code 10034214Term: Pediculus capitis (head louse)System Organ Class: 10021881 - Infections and infestations
EUCTR2011-000257-23-GBThornton & Ross Ltd84